Tourette syndrome (TS) is a genetically complex disorder for which no causative genes have been unequivocally identified. Nevertheless, a number of molecular genetic studies have investigated several candidate genes, particularly those implicated in dopamine modulation. The results of these studies were inconclusive, which may be due, at least in part, to the variable ethnicity of the patients included in different studies and the chosen research design. In this study, we used a family-based association approach to investigate the implication of dopamine-related candidate genes, which had been previously reported as possibly associated with TS [genes that encode for the dopamine receptors DRD2, DRD3 and DRD4, the dopamine transporter 1 (SLC6A3) and the monoamine oxidase-A (MAO-A). The studied group was composed of 110 TS patients. These patients were selected from the French Canadian population, which displays a founder effect. Excess transmission of the 7-repeat allele of the DRD4 exon-3 VNTR polymorphism (v 2 TDT ¼4.93, 1 df, P¼0.026) and the putative 'high-activity' alleles of the MAO-A promoter VNTR polymorphism (v 2 TDT ¼7.124, 1 df P¼0.0076) were observed. These results were confirmed in a subgroup of patients with no attention deficit/hyperactivity or obsessive compulsive comorbid disorders. Haplotype analysis using one or two supplemental polymorphism in each of these genes confirmed these associations and allowed one to identify risk haplotypes. No associations were found for DRD2, DRD3 or SLC6A3. These data support the notion that DRD4 and MOA-A genes may confer an increased risk for developing TS in the French Canadian population.
At the end of the nineteenth century, the French neurologist Georges Gilles de la Tourette described in detail the disorder that was later named after him. Since then, Tourette syndrome (TS) (also known as Tourette's or Gilles de la Tourette syndrome) is recognized mainly by the presence of chronic tics, which are both motor and phonic. TS is generally a childhood onset disorder, although in some cases the first symptoms are observed during adolescence, and always before 21 years of age. It is three to four times more common in boys than in girls, and its incidence may be as high as 0.5% of the population. 1 Since its early description by Gilles de la Tourette, the hereditary nature of this disorder was suspected and was subsequently confirmed during the second half of the twentieth century. 2, 3 Indeed, while identical twin pairs were shown to be highly concordant for TS (50-56%), only 8% of fraternal twins were concordant for this disorder, 4 suggesting that part of the risk to develop the disease is genetically determined.
To date, molecular genetic studies on TS have been based on different assumptions, and positive results have been obtained by linkage (parametric and nonparametric) and association analyses. 5 Overall, the results of these studies are difficult to interpret given that the replication of positive findings was relatively unfrequent. If multiple genes are implicated in TS, the lack of replication may be due to the small effects produced by each one of these genes. In addition, other study-design features such as ethnic heterogeneity among the analyzed populations and the use of case-control studies (sensitive to population structure biases) may also contribute to this nonreplication problem.
We used the transmission disequilibrium test (TDT), which has proven to be a robust family-based association analysis that compares the number of times an allele is transmitted (T) vs nontransmitted (NT) from a heterozygous parent to an affected offspring. 6 For the multiallelic markers, we used the extended TDT. 7 We only included patients from French Canadian origin. This ethnically homogeneous population has proven to be a very powerful tool to identify genes implicated both in monogenic Mendelian disorders 8 as well as complex disorders such as schizophrenia. 9 It has also been suggested that testing functional polymorphisms in candidate genes relevant to the disorder under investigation should be considered whenever possible. This approach may cast some biological validity on statistically significant results of association studies.
Genes involved in dopamine transmission are suitable candidates for TS. Indeed, neuroleptics, both typical and atypical, have been proven to improve the symptoms of TS in a dose-dependent fashion. 10 In addition, neuroimaging studies have found abnormalities in brain structures that are functionally related to the dopamine neurotransmission system. 11, 12 By searching the literature, we obtained a list of candidate genes coding for proteins implicated in dopamine pathways that have been positively associated and/or linked with TS (Table 1 ). The genes are the dopamine transporter gene (SLC6A3), the three D2-like dopamine receptor genes (DRD2, DRD3 and DRD4) and the monoamine oxidase-A gene (MAO-A).
Materials and methods

Subjects
A total of 330 DNA samples, belonging to 110 unrelated TS patients and their parents, were analyzed. The patients and their families were ascertained at the TS Clinic of the Allan Memorial Institute, and the Montreal General Hospital. The members of each family were interviewed by an interdisciplinary group, which was formed by a neurologist, a psychiatrist and a neuropsychologist. Clinical information was obtained for TS, attention deficit/hyperactivity disorder (ADHD) and obsessivecompulsive disorder (OCD). Symptoms were evaluated with semistructured interviews using standard scales. All the patients had definite TS defined by the DSM-IV and the TS Classification Study Group. 13, 14 Tic severity was evaluated using the Yale Global Tic Severity Scale, 15 which gives scores from 0 to 5 for motor and vocal tics. Obsessive-compulsive symptoms were evaluated by the Yale-Brown ObsesiveCompulsive scale. 16 ADHD symptoms were evaluated according to the DSM-IV criteria and the Conners questionnaire. 17 All the patients had full French Canadian ancestry, defined as having four French Canadian grandparents. Subjects were excluded from the study if there was any evidence of other neurological disorder that could mimic TS, if they had tics secondary to drug abuse or head injury, if they had a psychotic disorder, or neuroleptic-induced tardive dyskinesia. All subjects gave written informed consent after the study was explained to them. For children who agreed to participate in the study, the consent was also obtained from their parents.
Genotyping
SLC6A3 DNA was extracted from blood using standard phenol/chloroform methods. PCR reaction for the 40 bp VNTR was performed according to the method described by Vandenbergh et al. 18 The PCR products were electrophoresed on a 2.5% agarose gel and stained with ethidium bromide.
DRD2
The amplification for the TaqI polymorphism was performed according to a previously described method. 19 PCR product (10 ml) was digested with 5 U of TaqI enzyme (New England Biolabs) at 651C for 4 h and run on 2% agarose gels.
DRD3 PCR amplification for the MscI polymorphism was performed as previously described. 20 PCR products were digested with MscI (New England Biolabs) for 4 h at 371C and run on 3% agarose gels.
DRD4 PCR amplification for the exon 3, 48 bp-VNTR was performed according to Lichter et al., 21 modified by Grice et al. 22 PCR products were run on 2.2% metaphor agarose gels. All the samples were amplified at least two times in order to confirm the genotypes. A 25 bp ladder was used as a molecular weight marker (Invitrogen Life Technologies). The 120 bp duplication polymorphism at position À1200 in the promoter region was analyzed as previously described, 23 with a modified annealing temperature of 56-531C. Electrophoresis of PCR products was carried out on 1.5% agarose gels.
MAO-A Although the previously reported association for TS was not made with the promoter Tourette syndrome and dopaminergic genes A Díaz-Anzaldúa et al VNTR polymorphism, we chose to focus on this marker because of its suspected functional relevance. For this polymorphism, PCR amplification was performed as previously described, 24 adapted for a 20 ml reaction. The PCR products were run on 2.5% metaphor agarose gels (FMC Bioproducts). Two other polymorphisms, the Fnu4HI and EcoRV SNPs, were analyzed; PCR amplifications were performed according to previously described methods. 25 PCR products were digested with 5 U of the corresponding restriction enzyme (EcoRV and Fnu4H1, respectively) and were run on 2% agarose gels.
Results
There were 88 male and 22 female patients (4 : 1 male : female ratio). The mean age was 17 years (SD¼10). The age at onset for TS was 6 years (SD¼2). The frequency of tics, from 0 to 5, was 3 (SD¼1) for motor and 2 (SD¼2) for vocal tics. The forcefulness of tics was 2 (SD¼1) for motor and 2 (SD¼2) for vocal tics. Finally, interference was 2 (SD¼1) and 1 (SD¼1) for motor and vocal tics, respectively. In addition to TS, 56% of the patients had OCD and 40% had ADHD.
DRD4
Genotyping of exon 3 VNTR in the DRD4 gene revealed seven alleles corresponding to 2-, 3-, 4-, 5-, 6-, 7-and 8-repeats. Significant allele-wise (TDT w 2 ¼13.70, df¼6, P¼0.033) and genotype-wise (TDT w 2 ¼19.23, df¼10, P¼0.038) transmission disequilibrium was observed. As previous studies had found an association and/or linkage specifically between the 7-repeat allele (7) and TS, we focused mainly on its transmission ( Table 2 ) and found that it was significantly more transmitted to affected individuals (transmitted in 64% and nontransmitted in 36% of the cases, w 2 ¼5.88, df¼1, P¼0.015). As shown in Table 3 , we analyzed a subset of 38 TS patients who did not have comorbid ADHD or OCD and we also found an excess of transmission of the 7-repeat allele (w 2 TDT¼4.57, df¼1, P¼0.032).
Regarding the second DRD4 polymorphism analyzed, the 120 bp duplication at the promoter region, the frequencies of the S and L alleles were 0.23 and 0.77, respectively, in the TS unrelated subjects. Although no association was found with this polymorphism, a haplotype analysis focusing on allele 7 (exon 3) showed that this allele was generally cotransmitted with allele L (promoter). As indicated in Table 4 , the haplotype '7/L' was transmitted to TS patients more frequently than expected (w 2 ¼4.74, 1 df, P¼0.023) when compared to all the other haplotypes. Haplotype '7/S' was only observed five times, which prevented a statistical analysis. In contrast, allele S was observed in combination with allele 2 or 4 in 84% of the times. In total, 11 haplotypes were obtained (data not shown).
MAO-A
In the case of the MAO-A gene promoter VNTR polymorphism, genotyping revealed five different alleles distinguished by the number of their 30 bp repeat sequence: 2-, 3-, 3.5-, 4-and 5-repeat alleles. We compared the 'high-activity' vs the 'low-activity' alleles reported by Sabol et al. 24 We found that heterozygous parents preferentially transmitted the 'high-activity' alleles. From the total 'high-activity' alleles found in heterozygote parents, 68% were transmitted to the TS patients. In contrast, from the 'low-activity' alleles, only 33% were transmitted (Table 5) . We then analyzed the Fnu4H1 and EcoRV SNPs to test whether we could find a commonly transmitted haplotype. We found a significant excess of transmission of a 'high-activity' haplotype (3-1-1) High-activity alleles (2 and 3) vs 'low-activity' alleles (all but 2 and 3). w 2 ¼7.124, P¼0.0076.
Tourette syndrome and dopaminergic genes A Díaz-Anzaldúa et al formed by alleles of the promoter VNTR and both SNPs (Table 6 ). Haplotype '1-2-2', on the contrary, was significantly less transmitted to TS offsprings.
Other dopaminergic genes
For the dopamine transporter gene (SLC6A3), we identified alleles of 4, 6, 9, 10 and 11 copies. Alleles 4 and 6 were rarely observed, and they were never transmitted. As previously reported, allele 10 was frequently transmitted, but this was not statistically significant. Similarly, we could not find any association with the DRD2 TaqIA polymorphism, although there was a slight trend toward a higher allele A1 transmission (data not shown).
Concerning the DRD3 MscI polymorphism, we also failed to find an association with TS using the TDT test.
Discussion
Our sample differs from others previously reported in a number of ways. We used stringent criteria where only definite cases of TS were included and all the patients were from the French Canadian population, a founder population that had not been previously studied for association in TS.
In the present study, we found two associations with the strict diagnosis of TS. These associations were obtained for the DRD4 and the MAO-A genes, two genes that encode for proteins implicated in dopamine transmission. Our results were obtained with two functional polymorphisms, which may be an ideal characteristic for association studies in complex disorders. Furthermore, there was a haplotype transmitted more frequently than expected for both DRD4 and MAO-A.
The number of repeats in the DRD4 exon 3 polymorphism has been shown to affect the aminoacid sequence and probably the structure of the dopamine receptor. 21 Given that dopamine action is manifested through its binding with receptors such as DRD4, it is understandable that a change in DRD4 receptors themselves or in their regulatory regions could have an important effect on the transmission of dopamine. Furthermore, we found an excess of transmission of haplotype 7L, which could be explained by the frequent transmission of allele 7 and a possible linkage disequilibrium (in the French Canadian population) between this variant and allele L at the promoter region. Alternatively, allele L may have some effect in combination with allele 7. It has been reported that the promoter polymorphism contains the consensus binding sequences for several transcription factors, 23 and it may be that the levels of transcription of DRD4 differ according to the presence of allele L or allele S.
When the patients who had comorbid ADHD or OCD were excluded, we still found a biased transmission, which suggests, contrary to other reports, that a variable DRD4 activity may be associated with the presence of tics and not exclusively with the psychiatric comorbidities. Nevertheless, this subgroup was small and future analysis in a larger sample should be performed in order to confirm this result. It has been suggested that associations found between dopaminergic genes and TS, especially those regarding the DRD4 gene, may reflect a direct relationship with ADHD. Nevertheless, it is not clear whether patients who have ADHD and TS actually have different susceptibility genes than TS cases with no ADHD symptoms. Our study suggests that DRD4, either directly or through its proximity to another locus, is associated with the presence of chronic motor and vocal tics in TS patients.
MAO-A plays an important role in human behavior and physiology. It has been shown that transgenic mice with a deletion of this gene exhibit behavioral alterations such as trembling, and increased aggression in adult males. 26 The first polymorphism we analyzed affects the transcriptional activity of the gene promoter, and it has been suggested that there may be an optimal length of the regulatory region. 24 We observed only two common haplotypes in the mothers of TS patients. These haplotypes were '3-1-1' and '1-2-2', which is consistent with the proposed higher linkage disequilibrium at the MAO-A gene locus on the X chromosome when compared to other loci. 27 Nevertheless, even if there is linkage disequilibrium, this would not explain the preferential transmission of haplotype 3-1-1 to TS offsprings, a haplotype that can be considered as one conferring high activity. Such high activity of MAO-A in TS patients may lead to a higher rate of degradation of dopamine, which would not be easy to explain in this disease. However, in support of our findings, a previous report found that the activity levels of platelet MAO-A were significantly higher in 24 drug-free TS patients when compared to 24 healthy subjects matched for age and sex. 28 Given that TS shows a male predominance, it is reasonable to propose that an X-linked gene may be involved in this disease. A previous study suggested an X-linked modifier gene that affects the expression of TS. 29 Regarding the DRD3 gene, previous studies have found an excess of homozygosity of the MscI polymorphism in TS and other psychiatric disorders. 30 We could not detect any association with our 110 nuclear families alone, but we did observe an excess of homozygosity when our TS patients were compared ¼3.95, df¼1, P ¼0.047). The DRD2 receptor should be an excellent candidate for the study of TS, not only for its function and expression in areas thought to be relevant for TS but also because it is a principal target for neuroleptics. While previous studies found an association between TS and the TaqI polymorphism, other analyses excluded linkage to TS. 31, 32 We could not find any association with the TaqI polymorphism, but only a trend toward an excess of allele A1.
The dopamine transporter, the regulator that modulates the concentration of dopamine by removing it from the synaptic cleft and placing it back into the presynaptic neuron, was shown to be associated with TS at the genetic level, even when ADHD symptoms were removed from the analysis; 33 a similar result was found when analyzing behavioral variables in TS patients. 34 Our results, although not statistically significant, showed a trend towards the previously reported excess of transmission of allele 10 in TS patients.
The evidence gathered so far suggests that TS has an important genetic element and that genes involved in the dopamine pathway may be part of this component. This may be true even in the absence of comorbid ADHD or OCD, as supported by our results in a sample from the French Canadian population. Nevertheless, it is probable that TS, ADHD and OCD share at least some susceptibility genes. It should be noted that even when not all the results for various polymorphisms were statistically significant, we still found a trend for the same alleles reported to be associated with TS in the past. If our associations represent a true relationship with the susceptibility to TS, the fact that not all the patients have at least one copy of the DRD4 7 allele, or the high-activity alleles of MAO-A would be an indication of a probable locus heterogeneity for TS, even in founder populations like the French Canadians. TS is known to be a relatively common disorder, known for many centuries (even before its formal description at the end of the nineteenth century), which indicates that there may be allelic and locus heterogeneity.
